2023
Unlocking the Proteome - The NULISA™ Platform
Entrant Company
Halteres Associates
Category
Video - Medical
Client's Name
Alamar Biosciences
Country / Region
United States
Unlocking the Proteome -The NULISA™ Platform sets a new standard in proteomic analysis with attomolar sensitivity, allowing for unprecedented biomarker detection and quantitation.
By leveraging a proprietary sequential immunocomplex capture and release mechanism and the latest advances in Next Generation Sequencing (NGS), the NULISA technology provides both ultra-high sensitivity and scalable multiplexing.
Credits
Entrant Company
Midnight Brunch
Category
Branded Content - B2C
Country / Region
United States
Entrant Company
PPK
Category
Website - Games / Games-Related
Country / Region
United States
Entrant Company
Kairos Studio
Category
Corporate Identity - Brand Identity
Country / Region
United States
Entrant Company
Northwell Health
Category
Social Media - TikTok Page
Country / Region
United States